Trending Now
Cassava Sciences Inc (NASDAQ: SAVA) Announces Positive Data in Alzheimer’s Disease
Cassava Sciences Inc (NASDAQ: SAVA) aims to find and develop unique treatments for Chronic, neurodegenerative conditions. The company announced the positive Biomarker and Cognition...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Checkpoint Therapeutics Inc. (NASDAQ:CKPT) Announce Promising Results Of Cosibelimab in Treating...
Checkpoint Therapeutics Inc. (NASDAQ:CKPT) has announced interim results of its on-going open-label, multicohort, global Phase 1 clinical study of cosibelimab, its PD-L1 antibody in...
MAKE IT MODERN
LATEST REVIEWS
BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) Appoint Industry Veteran; AEterna Zentaris Inc....
The press release to the investor by the pharmaceutical companies reveals two distinct things. On the one hand, BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) Appoint...
MAKE IT MODERN
PERFORMANCE TRAINING
Axsome Therapeutics Inc. (NASDAQ: AXSM) Amends Its Term Loan Facility Agreement
Axsome Therapeutics Inc. (NASDAQ: AXSM) has announced the amendment of its current term loan facility agreement with Hercules Capital Inc. (NYSE: HTGC).
Axsome increases its...
Why Temas Resources Corp. Could Become the Biggest Commodities Breakout of 2022 (GOLD, BHP,...
The USA economy is trying hard to come back to the pre-pandemic normalcy. January has seen lots of up and down but...
Acer Therapeutics Inc (NASDAQ: ACER) Announces Breakthrough Therapy Designation For Celiprolol
Acer Therapeutics Inc (NASDAQ: ACER) has announced that its celiprolol therapy has received Breakthrough Therapy Designation from the FDA. The company has developed Celiprolol...
CBD For the Win (CWBHF, HMPQ, MJNA, CVSI, TRTC)
The CBD industry has been a roller coaster for early investors over the past 1-2 years. But the longer-term analysis in place...
Invesco QQQ stock hopes for a delayed Santa Rally
Invesco QQQ stock is currently trading at 266.26-0.50 (-0.19%). After shaking out dip buyers and those hoping for a Santa Rally yesterday the...
MAKE IT MODERN
